The prominent specific features of the H3K9me2 blocks enriched in AML, as compared to those enriched in CD34+, are the depletion of DNA methylation sites and density of CpG islands as well as the enrichment with vista enhancers (Fig 5). The gene discussed is CD34; the disease is acute myeloid leukemia.